Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.81 USD | +4.34% | +5.25% | +16.75% |
13/05 | Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating | MT |
09/05 | Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.75% | 158M | |
+26.37% | 44.96B | |
-1.01% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.34% | 26.08B | |
-21.69% | 19.03B | |
+6.23% | 12.75B | |
+26.99% | 12.06B | |
-3.38% | 11.75B |
- Stock Market
- Equities
- ACHV Stock
- News Achieve Life Sciences, Inc.
- Oppenheimer Adjusts Achieve Life Sciences PT to $20 From $27 Given Difficult Current Market Conditions, Maintains Outperform Rating